Apolipoprotein A5, a Crucial Determinant of Plasma Triglyceride Levels, Is Highly Responsive to Peroxisome Proliferator-activated Receptor α Activators
Open Access
- 1 May 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (20), 17982-17985
- https://doi.org/10.1074/jbc.m212191200
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.Human Molecular Genetics, 2002
- Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglyceridesHuman Molecular Genetics, 2002
- Apolipoprotein A-VJournal of Biological Chemistry, 2001
- An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative SequencingScience, 2001
- Evidence that triglycerides are an independent coronary heart disease risk factorThe American Journal of Cardiology, 2000
- Elevated Serum Triglyceride Levels and Long-Term Mortality in Patients With Coronary Heart DiseaseCirculation, 1999
- Families with Familial Combined Hyperlipidemia and Families Enriched for Coronary Artery Disease Share Genetic Determinants for the Atherogenic Lipoprotein PhenotypeAmerican Journal of Human Genetics, 1998
- Hypertriglyceridemia, Atherogenic Dyslipidemia, and the Metabolic SyndromeThe American Journal of Cardiology, 1998
- An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms.Proceedings of the National Academy of Sciences, 1993
- Familial combined hyperlipidaemia linked to the apolipoprotein AI–CIII–AIV gene cluster on chromosome 11q23q–q24Nature, 1991